Payer Perspectives on Drug Delivery
Fri, Oct 30
|
10:30 AM - 11:00 AM
Grand
Session details:
- How companies can position their drug delivery-enabled therapies for reimbursement
- The impact of direct-to-consumer accessibility on GLP-1 drugs
- Cell and gene therapies for non-malignancies and conditions for which there are already effective treatments.
